Cell Death and Disease · 2020 · 27 citations · 47 references
Life SciencesNeurobiologyNeuroscienceInflammationMolecular NeuroscienceNeuroimmunologyHuntington DiseaseLongevityMicroglia BiologyNeurodegenerative DiseasesNeurodegenerative DisordersNeuroinflammationHuntingtin ProteinHuntington Disease NeuroprotectionImmunomodulatory EffectsMicroglia CrosstalkNeural Cell DeathNeuroimmune Contributions To NeurodegenerationPolyglutamine DiseasesPolyglutamine Expansion Disorders
Abstract The longevity-associated variant (LAV) of the bactericidal/permeability-increasing fold-containing family B member 4 (BPIFB4) has been found significantly enriched in long-living individuals. Neuroinflammation is a key player in Huntington’s disease (HD), a neurodegenerative disorder caused by neural death due to expanded CAG repeats encoding a long polyglutamine tract in the huntingtin protein (Htt). Herein, we showed that striatal-derived cell lines with expanded Htt (STHdh Q 111/111 ) expressed and secreted lower levels of BPIFB4, when compared with Htt expressing cells (STHdh Q 7/7 ), which correlated with a defective stress response to proteasome inhibition. Overexpression of LAV-BPIFB4 in STHdh Q 111/111 cells was able to rescue both the BPIFB4 secretory profile and the proliferative/survival response. According to a well-established immunomodulatory role of LAV-BPIFB4, conditioned media from LAV-BPIFB4-overexpressing STHdh Q111 /111 cells were able to educate Immortalized Human Microglia—SV40 microglial cells. While STHdh Q 111/111 dying cells were ineffective to induce a CD163 + IL-10 high pro-resolving microglia compared to normal STHdh Q 7/7 , LAV-BPIFB4 transduction promptly restored the central immune control through a mechanism involving the stromal cell-derived factor-1. In line with the in vitro results, adeno-associated viral-mediated administration of LAV-BPIFB4 exerted a CXCR4-dependent neuroprotective action in vivo in the R6/2 HD mouse model by preventing important hallmarks of the disease including motor dysfunction, body weight loss, and mutant huntingtin protein aggregation. In this view, LAV-BPIFB4, due to its pleiotropic ability in both immune compartment and cellular homeostasis, may represent a candidate for developing new treatment for HD.
47
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin, Carrie Davis, Felix Schlesinger et al. · Bioinformatics · 2012 · 56.2K citations · Full text
Cutadapt removes adapter sequences from high-throughput sequencing reads
Marcel Martin · EMBnet journal · 2011 · 35.8K citations · Full text